Article thumbnail

Serotonin transporter (SERT) and translocator protein (TSPO) expression in the obese ob/ob mouse

By Gino Giannaccini, Laura Betti, Lionella Palego, Andrea Pirone, Lara Schmid, Mario Lanza, Laura Fabbrini, Caterina Pelosini, Margherita Maffei, Ferruccio Santini, Aldo Pinchera and Antonio Lucacchini
Topics: Research Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3044656
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2004). AJ: 5-HT2A/2C receptor and 5-HT transporter densities in mice prone or resistant to chronic high-fat diet-induced obesity: a quantitative autoradiography study. Brain Res
  2. (2005). amelanocyte-stimulating hormone and monoamines in food intake regulation. Nutrition
  3. (2006). Bombardieri S: Alteration of serotonin transporter density and activity in fibromyalgia. Arthritis Res Ther
  4. (2006). Bombardieri S: Peripheral benzodiazepine receptors on platelets of fibromyalgic patients. Clin Biochem
  5. (2001). C: 2-Arylpyrazolo[1,5-a]pyrimidin-3-yl Acetamides. New Potent and Selective Peripheral Benzodiazepine Receptor Ligands. Bioorg Med Chem
  6. (2006). CamejoHurt E: Reduced cholesterol accumulation by leptin deficient (ob/ob) mouse macrophages. Inflamm Res
  7. (1999). Cassano GB: Decreased platelet [ 3H]-paroxetine binding in untreated panic disorder patients. Life Sci
  8. (2001). Cassano GB: Decreased platelet [ 3H]-paroxetine binding sites in suicide attempters. Psychiatry Res
  9. (2005). Cassano GB: Peripheral-type benzodiazepine receptor binding sites in platelets of patients with panic disorder associated to separation anxiety symptoms. Psychopharmacology
  10. (1996). Cassano GB: The serotonin transporter from human brain: Purification and partial characterization. Neurochem Int
  11. (2009). Cholesterol transport in steroid biosynthesis: role of protein-protein interactions and implications in disease state. Biochim Biophys Acta
  12. (2000). Decreased 5-HT transporter mRNA in neurons of the dorsal raphe nucleus and behavioral depression in the obese leptin-deficient ob/ob mouse. Mol Brain Res
  13. (1983). GA: Diurnal rhythm for corticosterone in obese (ob/ob) diabetes (db/db) and goldthioglucose-induced obesity in mice. Endocrinology
  14. (2008). How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems. Neuropharmacology
  15. (1999). Increased binding at 5-HT1A, 5-HT1B and 5-HT2A receptors and 5-HT transporters in dietinduced obese rats. Brain Res
  16. (2003). Insulin signaling inhibits the 5-HT2C receptor in choroid plexus via MAP-kinase. BMC Neurosci
  17. (2007). Intracellular cholesterol changes induced by translocator protein (18 kDa) TSPO/PBR ligands. Neuropharmacology
  18. (2000). Intracerebroventricular infusion of leptin decreases serotonin transporter binding sites in the frontal cortex of the rat. Neurosci Lett
  19. (2005). L: Decreased density of peripheral benzodiazepine receptors in psychiatric patients after a suicide attempt. Life Sci
  20. (2004). La Cava A: The intricate interface between immune system and metabolism. Trends Immunol
  21. (2004). Leptin receptor signaling and the regulation of mammalian physiology. Recent Prog Horm Res
  22. (2002). Leptin signaling, adiposity and energy balance.
  23. (1985). LOWRY: A collection of radioligand binding analysis programs. Biosoft,
  24. (2009). Melcangi RC: Neuroprotective effects of a ligand of translocator protein-18KDa (Ro5-4864) in experimental diabetic neuropathy. Neuroscience
  25. (1996). ML: Serum immunoreactive-leptin concentrations in normal-weight and obese humans.
  26. (2000). Neuropetides and obesity. Nutrition
  27. (2007). Pinchera A: Tubby protein in human lymphocytes from normal weight and obese subjects. Clin Biochemistry
  28. Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states. M o lC e l lE n d o c r i n o l2010,
  29. (2003). Serotonergic activity measured by platelet [ 3H]-paroxetine binding in patients with eating disorders. Psychiatry Res
  30. (2002). Siciliano G: Peripheral benzodiazepine binding sites in platelets of patients affected by mitochondrial diseases and large scale mitochondrial DNA rearrangements. Mol Med
  31. (2007). The physiology of obese-hyperglycemic mice [ob/ob mice]. The Sci World J
  32. (1999). Weizman A: Enigma of the peripehral benzodiazepine receptor. Pharmacol Rev